Article
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
The Journal of antimicrobial chemotherapy - 1 Oct 2014
Zhanel George G, Wolter Kevin D, Calciu Cristina, Hogan Patricia, Low Donald E, Weiss Karl, Karlowsky James A
Abstract excerpt
BACKGROUND: Community-acquired respiratory tract infections (CARTI) are commonly caused by Streptococcus pneumoniae (SPN) and empirically treated with azithromycin. This study assessed clinical cure rates in azithromycin-treated subjects with CARTI caused by azithromycin-susceptible (Azi-S) or az...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.